Maze Therapeutics, Inc. (MAZE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2023: -$373.85M2024: -$311.18M2025: $354.97M$354.97M
2023Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$354.97M+214.1%
2024-$311.18M+16.8%
2023-$373.85M